 |
| CLICK HERE TO VIEW CURRENT ISSUE |
 |
| Best of NAMA 2026 |
|
 |
|
GOWAN ACQUIRES RIGHTS TO FUNGICIDE, HERBICIDE FROM DOW AGROSCIENCES
Nov. 11, 2010
Source: Gowan/Dow AgroSciences news release
Gowan Company, LLC has reached an agreement with Dow AgroSciences LLC to acquire the rights to M-Pede insecticide/fungicide and Scythe herbicide.
M-Pede is an OMRI certified insecticide/fungicide that controls aphids, thrips, and mites on a variety of crops including vegetables, grapes, tree fruits, tree nuts, cotton, and ornamentals. Scythe is a non-selective herbicide used for controlling a broad spectrum of weeds. These purchases are an excellent addition to Gowan Company's line of crop protection products and allow Dow AgroSciences to focus resources on priority solutions in its agricultural chemical portfolio, especially new molecules in the launch phase, as well as its growing biotechnology portfolio.
"This is part of Dow AgroSciences' ongoing portfolio management activities to maximize value and further our global growth strategy," said Pierre Flye Sainte Marie, global business leader for Growth Insecticides at Dow AgroSciences.
"The acquisition of M-Pede and Scythe will enhance Gowan Company's continued efforts to provide IPM solutions to growers around the world. The addition of these two products combined with Gowan's Aza-Direct brand solidifies our commitment to building a strong Green platform," said Sergio Comparini, Gowan Company business development manager.
Under this agreement, Gowan and its subsidiaries will start selling M-Pede and Scythe effective Nov. 10, 2010. Financial terms of the agreement were not disclosed.
Gowan Company, based in Yuma, AZ, is a family-owned registrant and marketer of crop protection products and champions technology for agriculture and horticulture through innovative product development, public advocacy and quality production.
Dow AgroSciences LLC, based in Indianapolis, Ind., is a top-tier agricultural company providing innovative agrochemical and biotechnology solutions globally. The company, a wholly owned subsidiary of The Dow Chemical Company, has sales of $4.5 billion.
|
|
|
|
|
